Join
Search

Posts Tagged ‘FDA’

Not Easy to Declare Independence from Sugar

Our Center for Science and Democracy has been busy studying sugar, its health impacts, and the ways that the sugar industry tries to undermine the science that shows that sugar is not a sweet deal for American families. Read More

Bookmark and Share

Added Sugar, Subtracted Science: A New Report and a Labeling Debate at the FDA

As a researcher focused on how science is used and misused in policy debates, I’ve seen more than my fair share of interference in (what should be) evidence-based decision making. But when I first dug into the details featured in our new report, Added Sugar, Subtracted Science, even I had to raise an eyebrow. Read More

Bookmark and Share

Spring Brings Hope–Even about Transparency and Accountability in Government

There is some good, albeit modest, news about the Food and Drug Administration and the way the agency addresses conflicts of interest on FDA advisory panels that consider the safety and efficacy of drugs and medical devices. Read More

Bookmark and Share

Finding Glimmers of Hope on Capitol Hill

The holidays are always a good time to take stock of the year, and to be grateful for the good things that happened. Although the media has labeled this the “do nothing” Congress, the news wasn’t all bad. Read More

Bookmark and Share

The Consequences of Killer Cantaloupes

If you follow food safety, you may have heard last week that brothers Eric and Ryan Jensen pled not guilty in federal court to charges of introducing adulterated food into interstate commerce. Read More

Bookmark and Share

We Don’t Have To Give Up Our Place To Special Interests: Democracy Gives Us Options

There is a practice in the Senate, primarily of corporate lobbyists, to hire low-income folks, usually minorities, to hold their place in line before Supreme Court or congressional hearings. There are firms that actually hire the standees, and contract with lobbying firms or corporations. Depending on the interest in the issue, standees can wait for hours before a hearing starts.  Last time I checked with one of them, a standee told me he earned $10 an hour. Read More

Bookmark and Share

Its Master’s Voice: The FDA’s Dependence on Drug Industry Fees

I’ve spent many years wondering why the Food and Drug Administration (FDA) has been so slow to curb the rampant overuse of antibiotics in agriculture. Read More

Bookmark and Share

Following Science, Judge Orders Over-the-Counter Access to Emergency Contraception drug Plan B

Chalk up a win for science. Federal Judge Edward Korman today ordered the Food and Drug Administration (FDA) to make “Plan B” emergency contraception available to women of all ages without a prescription, calling efforts to stop the FDA from doing so “arbitrary, capricious, and unreasonable.”

A federal judge has accomplished what two administrations failed to do: make a decision about access to a drug based on medical evidence. It’s just common sense for the government to make drug approval and access decisions solely based on the best available science, not on hunches or political calculations. The decision brings a decade of politics trumping science to an end.  Read More

Bookmark and Share

Freedom to Tweet: Grading Social Media Policies in the Federal Government

Social media can transform debates, inform discussions and, as we saw with the Arab spring, help spread democracy. And information and science have a key role to play in democracy (hence the new Center for Science and Democracy here at UCS). Scientists working for government agencies such as NASA, NOAA, the EPA, and the FDA have a lot to contribute to discussions about the science-based challenges we face. Unfortunately, agency policies combined with a culture of timidity are often constraining individual government scientists from jumping into social media. Read More

Bookmark and Share

Weaker Antibiotic Regulation: Another Problem with FDA’s Voluntary Cooperation Program

Last post, I described some of the features of the voluntary process that might convince veterinary drug companies to give up lucrative approvals to sell antibiotics for production purposes, like growth promotion and feed efficiency. Read More

Bookmark and Share